Dechow S, Abramovitch R
Microbiology (Reading). 2024; 170(5).
PMID: 38717801
PMC: 11165653.
DOI: 10.1099/mic.0.001458.
Malhotra V, Okon B, Satsangi A, Das S, Waturuocha U, Vashist A
Microbiol Spectr. 2022; 10(2):e0135421.
PMID: 35404097
PMC: 9045387.
DOI: 10.1128/spectrum.01354-21.
Li Y, Sharma M, Koripella R, Banavali N, Agrawal R, Ojha A
Microbiology (Reading). 2021; 167(2).
PMID: 33555244
PMC: 8131030.
DOI: 10.1099/mic.0.001035.
Choudhary E, Sharma R, Kumar Y, Agarwal N
Front Cell Infect Microbiol. 2019; 9:70.
PMID: 30972304
PMC: 6443821.
DOI: 10.3389/fcimb.2019.00070.
McAulay K, Saito K, Warrier T, Walsh K, Mathurin L, Royal-Mardi G
mBio. 2018; 9(6).
PMID: 30459198
PMC: 6247085.
DOI: 10.1128/mBio.02192-18.
Targeting Phenotypically Tolerant Mycobacterium tuberculosis.
Gold B, Nathan C
Microbiol Spectr. 2017; 5(1).
PMID: 28233509
PMC: 5367488.
DOI: 10.1128/microbiolspec.TBTB2-0031-2016.
Latent tuberculosis infection: myths, models, and molecular mechanisms.
Dutta N, Karakousis P
Microbiol Mol Biol Rev. 2014; 78(3):343-71.
PMID: 25184558
PMC: 4187682.
DOI: 10.1128/MMBR.00010-14.
Assessment of the Efficacy of New Anti-Tuberculosis Drugs.
Mitchison D, Davies G
Open Infect Dis J. 2013; 2:59-76.
PMID: 23814629
PMC: 3694317.
DOI: 10.2174/1874279300802010059.
Selective killing of nonreplicating mycobacteria.
Bryk R, Gold B, Venugopal A, Singh J, Samy R, Pupek K
Cell Host Microbe. 2008; 3(3):137-45.
PMID: 18329613
PMC: 2423947.
DOI: 10.1016/j.chom.2008.02.003.
Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy.
Warner D, Mizrahi V
Clin Microbiol Rev. 2006; 19(3):558-70.
PMID: 16847086
PMC: 1539104.
DOI: 10.1128/CMR.00060-05.
Bacterial population studies in chronic murine tuberculosis.
Rees R
Proc R Soc Med. 1961; 54:629-30.
PMID: 13740305
PMC: 1870475.
Transcription of two sigma 70 homologue genes, sigA and sigB, in stationary-phase Mycobacterium tuberculosis.
Hu Y, Coates A
J Bacteriol. 1999; 181(2):469-76.
PMID: 9882660
PMC: 93400.
DOI: 10.1128/JB.181.2.469-476.1999.
Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.
Herbert D, Paramasivan C, Venkatesan P, Kubendiran G, Prabhakar R, Mitchison D
Antimicrob Agents Chemother. 1996; 40(10):2296-9.
PMID: 8891133
PMC: 163523.
DOI: 10.1128/AAC.40.10.2296.
Chemotherapy of lepromatous leprosy: recent developments and prospects for the future.
GELBER R
Eur J Clin Microbiol Infect Dis. 1994; 13(11):942-52.
PMID: 7698121
DOI: 10.1007/BF02111496.
Dormancy of Mycobacterium tuberculosis and latency of disease.
Wayne L
Eur J Clin Microbiol Infect Dis. 1994; 13(11):908-14.
PMID: 7698116
DOI: 10.1007/BF02111491.
Influence of BCG-induced immunity on the bactericidal activity of isoniazid and rifampicin in experimental tuberculosis of the mouse and guinea-pig.
Dhillon J, Mitchison D
Br J Exp Pathol. 1989; 70(1):103-10.
PMID: 2493801
PMC: 2040531.
